Jagsonpal acquires 69.77% stake in Aequitas Healthcare, makes it subsidiary

Listed Co AcquisitionStrategic Transactions View source PDF

JAGSNPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-3.8%1-day move

₹237.90

prior close

—

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————-3.8-2.6-2.1-3.5-5.3-5.2-5.8———

Up moveDown movePending

AI summary

Jagsonpal Pharmaceuticals has acquired a 69.77% equity stake in Aequitas Healthcare Private Limited, making it a subsidiary. The company had earlier proposed to acquire an 85% stake, and this filing confirms the first part of the deal has been completed. The remaining stake purchase is still pending. The update was disclosed under SEBI LODR Regulation 30.

Likely market impact

Aequitas becomes a subsidiary, expanding Jagsonpal's healthcare presence. Consolidated results will include Aequitas from this date onward.